4 completed, 3 unknown, 2 active not recruiting, 1 not yet recruiting. 5 Not applicable, 4 Phase 2, 3 Phase 3, 1 Phase 1.
Follow Cancer of the Cervix: new trials by email Literature Review of Cancer of the Cervix trials Research Report on Cancer of the Cervix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer | Phase 2 | Not yet recruiting | Washington University School of Medicine | 42 | 2026-12-31 | 2026-09-03 |
| MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial Tumor collection via biopsy, Blood collection, Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI) - Locally Advanced Cervical Carcinoma, Locally Advanced Cervical Cancer | Not applicable | Recruiting | Washington University School of Medicine | 60 | 2024-01-11 | 2026-08-17 |
| Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2 cervix biopsy - Cancer of the Cervix, Conization of the Cervix | Not applicable | Unknown | Kaplan Medical Center | 52 | 2021-04-01 | 2021-04-30 |
| Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers FDG PET scan - Cancer of the Cervix, Vulvar Cancer | Phase 2 | Active not recruiting | Duke University | 90 | 2018-03-27 | 2026-10-22 |
| Ultrasound and Photoacoustic Imaging for Cervical Cancer Transvaginal probe using photoacoustic and ultrasound imaging - Cervical Cancer, Cancer of the Cervix | Not applicable | Terminated | Washington University School of Medicine | 2 | 2018-02-15 | 2020-05-29 |
| Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia Molecular testing for HPV, Liquid Based Cytology - Cancer of the Cervix, Cervical Intraepithelial Neoplasia | Not applicable | Active not recruiting | VCS Foundation | 76181 | 2015-01-01 | 2026-04-17 |
| Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial) Boost radiation - Cancer of the Cervix, Cervical Neoplasms | Not applicable | Completed | Duke University | 12 | 2012-06-04 | 2021-02-08 |
| Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation Granisetron, Ondansetron, Questionnaires - Cancer of the Cervix | Phase 3 | Completed | M.D. Anderson Cancer Center | 76 | 2012-03-01 | 2021-06-11 |
| A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer Sorafenib, Cisplatin, Radiation - Cancer of the Cervix | Phase 1 / Phase 2 | Completed | University Health Network, Toronto | 13 | 2007-06-01 | 2015-07-27 |
| Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma Cetuximab - Cancer of the Cervix | Phase 2 | Unknown | University of Virginia | 30 | 2006-02-01 | 2011-05-30 |
| Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients Radiotherapy alone, Radiotherapy with cisplatin - Cancer of the Cervix | Phase 3 | Unknown | International Atomic Energy Agency | 322 | 2004-12-01 | 2011-10-13 |
| High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix HIgh Dose Rate Vs Low DOse Rate Brachytherapy - Cancer of Cervix, Cervical Cancer | Phase 3 | Completed | Tata Memorial Hospital | 750 | 1996-05-01 | 2015-05-06 |
Uterine Cervical Neoplasms (12) · Acquired Immunodeficiency Syndrome (1) · Anal Canal Carcinoma (1) · Barakat syndrome (1) · Carcinoma (1) · Esophageal Neoplasms (1) · Nausea (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Uterine Cervical Dysplasia (1) · Vomiting (1) · Vulvar Neoplasms (1)
Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Genital Diseases (12) · Genital Diseases, Female (12) · Genital Neoplasms, Female (12) · Neoplasms by Site (12) · Urogenital Diseases (12) · Urogenital Neoplasms (12) · Uterine Cervical Diseases (12) · Uterine Diseases (12) · Uterine Neoplasms (12) · Neoplasms (11) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Blood-Borne Infections (1)
Cisplatin (3) · Radiotherapy (2) · Blood Specimen Collection (1) · Cetuximab (1) · Granisetron (1) · Magnetic Resonance Imaging (1) · Magnetic Resonance Spectroscopy (1) · Molecular Diagnostic Techniques (1) · Ondansetron (1) · Radiation (1) · Sorafenib (1) · Surveys and Questionnaires (1) · Ultrasonography (1)
Washington University School of Medicine (3) · Duke University (2) · International Atomic Energy Agency (1) · Kaplan Medical Center (1) · M.D. Anderson Cancer Center (1) · Tata Memorial Hospital (1) · University Health Network, Toronto (1) · University of Virginia (1) · VCS Foundation (1)
United States (7) · India (2) · Australia (1) · Canada (1) · Israel (1) · South Africa (1) · Tanzania (1) · Uganda (1) · Zimbabwe (1)
Junzo Chino, MD (2) · Amit Oza, MD FRCP (1) · Eduardo H. Zubizarreta, M.D. (1) · Julie K Schwarz, M.D., Ph.D. (1) · Karen Canfell, BE, D.Phil. (1) · Linda R. Duska, M.D. (1) · Marion Saville, M.B., Ch.B (1) · Michael M. Frumovitz, MD, MPH (1) · Michael Milosevic, MD FRCPC (1) · Michael Waters, M.D., Ph.D. (1) · Perry W Grigsby, M.D. (1) · Shyamkishore J Shrivastava, MD, DNB (RT) (1)
PMID 27112193, PMID 33041337, PMID 33256726, PMID 35696702, PMID 39915917, PMID 40090212, PMID 41263263
R01CA181745 (1), U54CA274318 (1)